USCB Financial Holdings, Inc. (USCB) stock analysis
Close on Nov 11, 2026Market cap $369.31MP/E –Yield –
StockData Score
Prices as of Nov 11, 2026How the score works
Weak8 of 30 checks passed
USCB Financial passes 8 of the 30 checks behind our score; 11 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 0/6
- Growth
- 0/6
- Past performance
- 4/6
- Financial health
- 1/6
- Dividend
- 3/6
What stands out
Earnings grew over 5 years
Net income grew 19.3% a year on average over the last five fiscal years.
Covered by free cash flow
Dividends take 20.2% of free cash flow.
Covered by earnings
Dividends take 29.7% of net income.
Return on assets over 1%
Return on assets was 1.0%; for a bank or insurer, 1% or more is considered good.
What to watch
Return on equity under 15%
Return on equity was 13.4% over the last twelve months and averaged 10.9% over five years; we look for 15% on both.
Revenue growing under 10% a year
Revenue grew 9.4% a year over the last three fiscal years, short of the 10% we look for.
Earnings growth not accelerating
Net income grew -7.3% over the last twelve months, against a 5-year average of 19.3% a year.
Thin capital
Equity is 7.6% of total assets; 8% or more is a comfortable cushion.
Valuation0/6
P/E against its history
Not enough price and earnings history to compare.
P/E against the industry
Needs positive earnings and enough profitable companies in the industry.
P/S above the industry
USCB Financial's price-to-sales of 3.72 is above the Commercial Banks median of 3.60.
P/B above the industry
USCB Financial's price-to-book of 1.61 is above the Commercial Banks median of 1.29.
Price against fair value
We could not estimate a fair value: it needs at least two valuation methods with positive inputs.
Margin of safety
Depends on the fair value estimate.
Growth0/6
Revenue growing under 10% a year
Revenue grew 9.4% a year over the last three fiscal years, short of the 10% we look for.
EPS growth over 3 years
Needs positive EPS three years ago and today.
Earnings growth not accelerating
Net income grew -7.3% over the last twelve months, against a 5-year average of 19.3% a year.
Growing slower than the industry
Revenue grew 4.2% over the last twelve months; the Commercial Banks median is 11.3%.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin trend
Banks and insurers do not report gross profit.
Past performance4/6
Return on equity under 15%
Return on equity was 13.4% over the last twelve months and averaged 10.9% over five years; we look for 15% on both.
Return on assets over 1%
Return on assets was 1.0%; for a bank or insurer, 1% or more is considered good.
Return on equity above the industry
USCB Financial's return on equity of 13.4% is above the Commercial Banks median of 11.5%.
Earnings grew over 5 years
Net income grew 19.3% a year on average over the last five fiscal years.
Net margin above its 5-year average
Net margin was 29.6% over the last twelve months, against a 5-year average of 29.3%.
Net margin below the industry
USCB Financial's net margin of 29.6% is below the Commercial Banks median of 30.3%.
Financial health1/6
Thin capital
Equity is 7.6% of total assets; 8% or more is a comfortable cushion.
Loans funded by deposits
Needs loans and deposits.
Adequate loan-loss reserve
The allowance for credit losses is not reported.
Efficient operations
Non-interest expense takes 57.2% of revenue; under 60% is efficient for a bank.
Deposits shrinking
Deposits fell 0.4% over the past year.
Borrowings
Needs debt and equity figures.
Dividend3/6
Pays a dividend
USCB Financial paid dividends worth 2.4% of the share price over the last twelve months.
Yield below Treasuries
The 2.4% yield is below the 4.4% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.8% or more; USCB Financial yields 2.4%.
Dividend stability
Fewer than five years of dividend history.
Covered by earnings
Dividends take 29.7% of net income.
Covered by free cash flow
Dividends take 20.2% of free cash flow.
Fair value
How we estimate itWe don't publish a fair value for USCB Financial. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
High risk
- Average value traded per day
- $1.75M
- Value traded per 1% price move
- $1.55M
Downside
Low risk
- Typical loss in a bad month
- 10.9%
- Volatility (annualized)
- 28%
- Sharpe ratio, 1 year
- 0.22
- Beta to the S&P 500 (5Y)
- 0.53
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2019 to 2025
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +9.1% | +9.4% | +12.7% | – | |
| Net income | +5.8% | +9.0% | +19.3% | – | |
| EPS, diluted | +7.3% | – | – | – | |
| Free cash flow | +23.1% | +13.8% | +27.2% | – |
Returns and balance sheet
7 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2019 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | 6.5% | 12.1% | |
| Return on assets | – | – | 1.0% | |
| Capex to revenue | – | 0.7% | 0.3% | |
| Diluted shares | – | – | 20M |
Where the cash went
Fiscal 2021 to 2025, five years combined
USCB Financial generated $151.78M from operations and spent $58.57M on capital expenditure, dividends and share buybacks. 4% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 28.9% | 0.03× | 12.42× | 12.1% |
| FY2024 | 29.8% | 0.03× | 12.08× | 12.1% |
| FY2023 | 25.1% | 0.03× | 11.82× | 8.8% |
| FY2022 | 29.2% | 0.03× | 10.20× | 10.4% |
| FY2021 | 33.4% | 0.04× | 8.95× | 11.2% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$26.10M
- Cash generatingOperating cash flow above zero$42.81M
- Return on assets improvedROA up on the prior year1.1% → 1.0%
- Earnings backed by cashOperating cash flow above net income$42.81M vs $26.10M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose– → –
- No dilutionShare count did not rise20M → 20M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.04 → 0.03
See a number that looks wrong?